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The aim of this chapter is to comparе structural characteristics and invasive features of 
papillary thyroid carcinomas (PTCs) between the groups of patients who were children at 
the time of the Chernobyl accident and thus were exposed to radioactive iodine in fallout 
(the radiogenic cancers) and those who were born since 1987 and were not irradiated (so-
called sporadic cancers). We recognize that the radiogenic group will inevitably include 
some cases of non-radiation aetiology, and attempted to minimize these through the 
process of selection described below.
In Chapter 3 and our previous papers [1-5] it has been shown that thyroid cancer 
incidence was significantly higher in the six northern Ukraine regions with high levels of 
contamination by radioactive iodine. Among these, three areas are the most affected: Kiev, 
Zhytomir, and Chernigov regions. A simple calculation of the number of cases per 1,000 
residents in relevant populations for 25 years (from 1986 to 2010) demonstrates evident 
difference: it is about 3 times higher in those exposed as children and 2 times higher in 
those exposed as adolescents as compared with less contaminated regions (Table 5.1).
Table 5.1 
Number of cases and prevalence per 1,000 of population of thyroid cancer cases in Ukraine 
in subjects who were children and adolescents at the time of Chernobyl accident
Children Adolescents Total
Whole of 
Ukraine 5044/11100000=0.5/1000 1642/2200000=0.8/1000 6686/13300000=0.5/1000
21 less or not 
contaminated 
regions 2861/8900000=0.3/1000 1078/1760000=0.6/1000 3939/10660000=0.4/1000
3 out of 6 most 
contaminated 
regions 1098/1025000=1.1/1000 254/195000=1.3/1000 1352/1220000=1.1/1000
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Also, as was reported earlier [6-9], the highest dose-dependent additional incidence was 
observed in children whose age in 1986 did not exceed 4 years. It therefore is reasonable 
to assume that the fraction of papillary carcinomas attributable to radiation would be the 
largest among those whose age at exposure ranged from 0 to 4 years and who at the time 
of accident were residents of the three most affected regions of Ukraine (Kiev, Chernigov, 
and Zhytomir regions). 
For this reason, for the present investigation we selected pathological data for the 
period from 1990 to 2010 (see Chapter 4), and included in the analysis only cases diagnosed 
in residents of the three most contaminated regions who were aged up to 4 years at 
Chernobyl. These are: 114 out of 272 PTCs in children aged up to 14 years at surgery, 66 
out of 225 in adolescents aged from 15 to 18 years at surgery, and 59 out of 361 РТСs in 
adults aged 19-23 years. Age at surgery in adults was limited from 19 to 23 years since 
among patients born after Chernobyl no one was older than 23 years in 2010. All 264 PTCs 
detected in subjects born after the accident were included in the analysis regardless of 
their place of residence because all these cases are sporadic. Characterstics of the age-
matched groups are specified in Table 5.2.  
Table 5.2 
Age-matched groups of radiogenic and sporadic PTC in the study
Number of cases Mean age       F:M
Radiogenic Sporadic Radiogenic Sporadic Radiogenic Sporadic
Children 114 111 11.6 12.0 68:46=1.5:1 83:28=3.0:1
Adolescents 66 97 16.8 16.8 44:22=2.0:1 72:25=2.9:1
Adults 59 56 21.2 20.8 44:15=2.9:1 46:10=4.6:1
In all groups, both in radiogenic and sporadic PTCs, female patients were prevailing, 
but in the group of children with radiogenic tumors the proportion of male patients was 
greater as compared with the group of children with sporadic carcinomas (Table 5.2), with 
a substantial difference in F:M ratio (1.5:1 vs 3:1, respectively). 
There were no significant differences in mean size of tumor when comparing either 
different age groups or radiogenic and sporadic carcinomas in each age group. In children 
with radiogenic РТС the frequency of microcarcinomas measuring up to 10 mm was 
2.2 times lower as compared to children with sporadic РТС (Table 5.3) suggesting that 
screening had not shifted tumor size to the lower values in the exposed regions. 
Table 5.3
Mean size of radiogenic and sporadic PTC in the study
Children Adolescents Adults
Radiogenic Sporadic Radiogenic Sporadic Radiogenic Sporadic
Mean size 
(mm) 23.6 24.0 19.1 23.3 20.6 21.3
≤10 mm: 
n (%) 7/114(6.1) 5/111(13.5) 14/66(21.2) 16/97(16.5) 13/59(22.0) 13/56(23.2)
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It should be emphasized that “architecturally” all PTCs under study, regardless of patients’ 
date of birth or age at diagnosis, were almost all represented by three common histological 
variants: classical papillary, follicular, solid, and by the mixed-type tumors (herein reffered 
to as “mixed variant”) which comprise combinations of the mentioned growth patterns. 
The diffuse-sclerosing variant was identified in a small number of cases (mainly among 
children), and there were isolated cases of Warthin-like and Cribriform-morular variants 
(Table 5.4). Among the mixed variants of PTC, the papillary-follicular and solid-follicular 
combinations were most frequent (Table 5.5). 
Comparison of radiogenic РТСs selected for the present analysis with all morphologically 
studied cases in patients born before the Chernobyl accident (described in the previous 
chapter) shows that such a selection did not result in changes in the distribution of main 
PTC subtypes, in the ratio of structural components of mixed variant, or frequency of the 
combined (solid+solid-follicular and papillary+papillary-follicular) variants in all age groups 
(see Tables 4.4, 4.5 of Chapter 4 and Tables 5.4, 5.5, 5. 6 of this Chapter). Despite the maximum 
age of adult patients has considerably decreased after selection (from 42 years in the total 
group to 23 years in the selected group), all significant linear age trends (assessed by the 
Chi-square test for trend) identified in the previous chapter, were preserved. In the selected 
groups of PTCs, linear decreasing trends of frequency of solid, solid-follicular and combined 
(solid+solid-follicular) variants (p<0.0115; p<0.0009; p<0.0001, respectively), and increasing 
linear trends of frequency of papillary, papillary-follicular and combined (papillary+papillary-
follicular) variants in the age series of children-adolescents-adults remained unchanged 
(p<0.0001; p<0.0013; p<0.0001, respectively). A significant increasing linear age trend was 
also noted for the frequency of fully encapsulated РТСs (p<0.0001, Table 5.7). 
The selection had no effect on the invasive properties of radiogenic PTCs either (Table 
4.8 of Chapter 4 and Table 5.7 of this Chapter). In the selected cases, significant decreasing 
linear trends of frequency of intrathyroidal spread and extrathyroidal extension, vascular 
invasion, regional and distant metastases in the age series of children-adolescents-adults 
were also confirmed (all trends, p<0.0001). 
Thus, our selection of cases by patients’ age and place of residence at the time of 
the Chernobyl accident was not associated with significant changes in morphological 
characteristics of PTCs determined in corresponding age groups for the whole of Ukraine, 
i.e. there was no detectable selection bias. 
Considering the frequency of histological subtypes in sporadic PTCs (in patients born 
after the Chernobyl accident), it should be noted that the linear trends similar to those in 
radiogenic cancers were not found in age series (Tables 5.4, 5.5, 5.6) except for a decreasing 
trend in the frequency of solid variant (p<0.0502, marginally). Analysis of encapsulated 
PTCs also showed no age relationship (Table 5.7). 
By contrast, invasive properties of sporadic (Table 5.7) as well as of radiogenic PTCs were 
significantly decreasing in the age series of children-adolescents-adults (intrathyroidal 
extension, p<0.0470; extrathyroidal extension, p<0.0001; vascular invasion, p<0.0008; 
regional metastases, p<0.0004, distant metastases to the lung, p<0.0106). 
Conceivably, radiogenic and sporadic papillary carcinomas, when comparison is 
performed in the age series, are characterized by the same trends for invasive features, but 




Subtypes of PTC in patients born before (radiogenic) and after Chernobyl (sporadic cancers)
Children up to 14 y.o. at surgery Adolescents 15-18 y.o. at surgery Adults 19-23 y.o. at surgery
Radiogenic Sporadic Radiogenic Sporadic Radiogenic Sporadic
n % n % n % n % n % n %
Classic papillary 11 9.6 18 16.2 14 21.2 28 28.9 20 33.3 12 21.4
Follicular 25 21.9 17 15.3 14 21.2 9 9.3 13 22.0 8 14.3
Solid 24 21.1 17 15.3 5 7.6 10 10.3 5 7.5 3 5.3
Mixed 47 41.3 54 48.7 31 47.0 48 49.5 21 35.6 29 51.8
Diffuse-sclerosing 7 6.1 5 4.5 1 1.5 1 1.0 - - 1 1.8
Warthin-like - - - - 1 1.5 1 1.0 - - 2 3.6
Cribriform - - - - - - - - - - 1 1.8
Total 114 100 111 100 66 100 97 100 59 100 56 100
Table 5.5 
Structural combinations of mixed subtypes of PTC in patients born before (radiogenic) and after Chernobyl (sporadic cancers)
Children up to 14 y.o. at surgery Adolescents 15-18 y.o. at surgery Adults 19-23 y.o. at surgery
Radiogenic Sporadic Radiogenic Sporadic Radiogenic Sporadic
n % n % n % n % n % n %
Papillary-follicular 9 19.1 20 37.0 13 41.9 19 39.6 12 57.1 7 24.1
Papillary-solid 5 10.6 10 18.5 8 25.8 8 16.7 3 14.3 6 20.7
Papillary-follicular-
solid
2 4.3 7 13.0 1 3.2 6 12.5 - - 4 13.8
Solid-follicular 31 66.0 17 31.5 9 29.0 15 31.2 6 28.6 12 41.4
Total 47 100 54 100 31 100 48 100 21 100 29 100
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PTCs with most prominent solid patterns (SV+SFV) and most prominent papillary patterns (PV+PFV) in patients born before 
(radiogenic) and after Chernobyl (sporadic cancers)
Children up to 14 y.o at surgery Adolescents 15-18 y.o at surgery Adults 19-23 y.o at surgery
Radiogenic Sporadic Radiogenic Sporadic Radiogenic Sporadic
n % n % n % n % n % n %
Solid+Solid-Follicular 
variants
55/114 48.2 34/111 30.6 14/66 21.2 25/97 25.8 11/59 18.6 15/56 26.8
Papillary+Papillary-
Follicular variants
20/114 17.5 38/111 34.2 27/66 40.9 47/97 48.5 32/59 54.2 19/56 33.9
Table 5.7 
Invasive proprties and tumor encapsulation in patients born before (radiogenic) and after Chernobyl (sporadic cancers)
Children up to 14 y.o at surgery Adolescents 15-18 y.o at surgery Adults 19-23 y.o at surgery
Radiogenic Sporadic Radiogenic Sporadic Radiogenic Sporadic
n % n % n % n % n % n %
Intrathyroidal exten-
sion
97 85.1 74 66.7 35 53.0 61 62.9 35 59.3 28 50.0
Extrathyroidal exten-
sion
76 66.7 60 54.1 30 45.0 40 41.2 19 32.2 12 21.4
Multifocality 7 6.1 11 9.9 7 10.6 11 11.3 5 8.5 9 16.1
Vascular invasion 97 85.1 79 71.2 44 66.7 64 66.0 27 45.8 24 42.9
Regional metastases 77 67.5 71 64.0 35 53.0 54 55.7 16 27.1 19 33.9
Distant metastases 27 23.8 14 12.6 9 13.6 6 6.2 - - 1 1.8
Fully encapsulated 6 5.3 22 19.8 10 15.2 15 15.5 19 32.2 15 26.8
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Taking into account that earlier comparative analyses of PTC in children and adolescents 
of Ukraine, Belarus, and Russia born before and after Chernobyl have not revealed substantial 
morphological differences [10-14], in the present study we used deepened univariate and 
multivariate statistical approaches to each of the three age-matched groups. 
To compare pathological parameters between radiation-induced and sporadic PTC 
by univariate analysis, Fisher exact test (FT) was used for categorical data, and two-tailed 
Mann-Whitney test  for quantitative measurements. 
Univariate statistical analysis of main subtypes of PTC in children (Table 5.8) showed 
that among radiogenic РТСs the frequency of tumors with solid-follicular strucuture (solid 
+ solid-follicular variants) was significantly higher than that in sporadic РТСs (p<0.009). 
Conversely, the frequency of sporadic РТСs with papillary-follicular structure (papillary + 
papillary-follicular variants, p<0.006) was significantly higher than in radiogenic tumors.  
Comparison of invasive features also revealed the most pronounced differences in childhood 
groups: radiogenic PTCs were characterized by a significantly higher frequency of intrathyroidal 
extension (p<0.002), vascular invasion (p<0.015) and distant metastases (p<0.033). 
In addition, in the group of children with radiogenic РТС, a significantly lower frequency 
was observed for the fully encapsulated tumors as compared with sporadic РТСs (p<0.001), 
and for the frequency of microcarcinomas sized up to 10 mm, but the difference is not quite 
statistically significant (p<0.074). The groups of children with radiogenic and sporadic РТСs 
also differed significantly in F:M ratio (p<0.026) as mentioned above.
Among adolescents and adults no significant differences between  any of the above 
parameters were observed (Table 5.8).
Multivariate analysis in each age group of patients was performed using standard 
logistic regression modeling. The following variables were tested: 
age at surgery (continuous; years);
sex (categorical, M or F);
tumor size ≤10mm or  >10 mm (categorical; yes or no); 
complete tumor capsule (categorical; yes or no);
histological subtype (categorical; solid+solid follicular or other);
lymph node metastases (categorical; yes or no); 
distant metastasis to the lung (categorical; yes or no); 
intrathyroidal spread (categorical; yes or no); 
extrathyroidal extension (categorical; yes or no); 
multifocality (categorical; yes or no); 
vascular invasion (categorical; yes or no).
Non-automatic backward elimination was applied to the full model that initially 
included all the variables listed above. Once the most appropriate model was determined, 
the maximum likelihood estimates of the respective parameters and their 95% confidence 
intervals were calculated.
Multivariate logistic regression analysis (Table 5.9) confirmed significant differences 
between radiogenic and sporadic PTCs in children. Four parameters (male gender, absence 
of tumor capsule, solid+solid-follicular tumor architecture, and a higher frequency of 
intrathyroidal spread) were found to be independently associated with radiogenic PTC. The 
fifth parameter, the higher frequency of lymph node metastases, showed just marginal 
association with radiogenic PTCs.
115
Comparative pathological analysis of papillary thyroid carcinoma in age-matched groups ....
Table 5.8  
Univariate statistical analysis of PTCs in patients born before (radiogenic) and after 
Chernobyl (sporadic cancers) in age-matched groups
Children
Parameters OR 95% CI p-value
Sex  (M  vs  F) 1.89 1.08-3.35 0.026
Age at operation (years) 0.93 0.83-1.04 0.190
Tumor size (≤10 mm  vs  >10 mm) 0.42 0.16-1.07 0.074
Tumor capsule (yes  vs  no) 0.22 0.09-0.58 0.001
Subtype (solid+solid-follicular  vs  other) 2.11 1.22-3.64 0.009
pN (pN1  vs  pN0) 1.14 0.66-1.99 > 0.5
M  (M1  vs  M0) 2.13 1.06-4.42 0.033
Multifocality (yes  vs  no) 0.59 0.21-1.56 0.287
Intrathyroidal extension  (yes  vs  no) 2.78 1.47-5.43 0.002
Extrathyroidal extension  (yes  vs  no) 1.67 0.97-2.88 0.063
Vascular invasion  (yes  vs  no) 2.31 1.97-4.47 0.015
Adolescents
Parameters OR 95% CI p-value
Sex  (M  vs  F) 1.44 0.73-2.86 0.379
Age at operation (years) 1.01 0.76-1.33 > 0.5
Tumor size (≤10 mm  vs  >10 mm) 0.69 0.29-1.64 0.394
Tumor capsule (yes  vs  no) 0.92 0.38-2.14 > 0.5
Subtype (solid+solid-follicular  vs  other) 0.78 0.37-1.63 > 0.5
pN (pN1  vs  pN0) 0.92 0.49-1.72 > 0.5
M  (M1  vs  M0) 2.42 0.83-7.56 0.106
Multifocality (yes  vs  no) 0.94 0.33-2.52 > 0.5
Intrathyroidal extension  (yes  vs  no) 0.69 0.36-1.29 0.241
Extrathyroidal extension  (yes  vs  no) 1.21 0.64-2.27 > 0.5
Vascular invasion  (yes  vs  no) 1.03 0.53-2.00 > 0.5
Adults
Parameters OR 95% CI p-value
Sex  (M  vs  F) 1.57 0.64-3.96 0.324
Age at operation (years) 1.28 0.96-1.73 0.097
Tumor size (≤10 mm  vs  >10 mm) 0.94 0.34-2.53 > 0.5
Tumor capsule (yes  vs  no) 1.30 0.58-2.94 > 0.5
Subtype (solid+solid-follicular  vs  other) 0.63 0.26-1.51 0.374
pN (pN1 vs  pN0) 0.72 0.32-1.61 0.427
Multifocality (yes  vs  no) 0.48 0.14-1.50 0.211
Intrathyroidal extension  (yes  vs  no) 1.46 0.70-3.07 0.315
Extrathyroidal extension  (yes  vs  no) 1.74 0.76-4.12 0.191




Results of multivariate statistical analysis of PTC in patients born before (radiogenic) and 
after Chernobyl (sporadic cancers) in age-matched groups
Children
Parameters OR 95% CI p-value
Sex  (M  vs  F) 1.86 1.02-3.43 0.042
Tumor capsule (yes vs no) 0.27 0.09-0.73 0.009
Subtype (solid+solid-follicular vs  other) 1.89 1.05-3.33 0.031
pN (yes vs no) 1.89 0.96-3.70 0.064
Intrathyroidal spread  (yes  vs no) 2.80 1.36-5.98 0.005
Adolescents
Parameters OR 95% CI p-value
Extrathyroidal extension  (yes  vs  no) 3.00 1.07-9.91 0.037
Adults
Parameters OR 95% CI p-value
Age at operation (older  vs  younger) 1.49 1.08-2.12 0.014
pN (yes vs no) 0.34 0.11-0.93 0.034
Multifocality (yes vs no) 0.32 0.08-1.05 0.060
Extrathyroidal extension  (yes  vs  no) 3.56 1.25-1.51 0.017
In adolescents, only a higher chance of extrathyroidal extension in radiogenic РТСs was 
noted. In adults, the logistic regression revealed a significant association for four parameters: 
age at surgery, lymph node metastases, and extrathyroidal extension. A higher frequency 
of extrathyroidal extension was associated with radiogenic РТСs. On the contrary, a higher 
frequency of lymph node metastases, younger age and higher frequency of multifocality 
(marginally) were associated with sporadic РТСs (Table 5.9). Of note, univariate statistical 
analysis showed no significant differences for any of these parameters in adolescents and 
adults. 
Thus, radiogenic papillary carcinomas in each of the age-matched groups had certain 
differences from sporadic ones. The most pronounced differences were observed in age-
matched groups of children; these were confirmed on both univariate and multivariate 
statistical analyses. 
The data obtained suggest that after radiation exposure at the age 0-4 years old, 
the most rapidly progressing towards clinical manifestations PTCs (latency in subjects 
operated on in childhood ranged from 3.8 to 13.8 years, mean 9.4 years, Table 5.10) were 
independently associated with the solid and/or solid-follicular growth pattern, absence 
of tumor capsule, and such an aggressive morphological feature as intrathyroidal spread 
as compared to sporadic PTCs in the age-matched group. It should be noted that the 
higher aggressiveness of radiogenic Chernobyl papillary carcinomas in children of Ukraine 
and Belarus with a shorter latency was associated with the presence of a marked solid 
component, as reported in our previous study [15].
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Apparently, the slower development of radiogenic tumors in adolescents and adults 
(mean latency 14.4 and 18.8 years, respectively, Table 5.10) levels off the differences in 
histological architectonics seen in children. On multivariate analysis, associations were 
found only for the greater chance of extrathyroidal extension in adolescents and adults 
and also for the lower chance of nodal disease in adults, but no correlation was found with 
tumor morphology in these age groups. 
It is worth noting that such a “convergence” of morphological characteristics between 
radiogenic and sporadic PTCs with increasing patients’ age and, naturally, the latency 
of radiogenic tumors, could perhaps be explained, at least in part, by different thyroid 
doses received during the Chernobyl accident by children at surgery on one hand, and 
adolescents and/or adults at surgery on the other. This hypothesis is based on the results 
of our cohort studies obtained within the Ukrainian-American Project [16]. It was shown 
that after the 1st screening during the period 1998 to 2000 (mean latency 14.6 years), the 
number of thyroid cancer cases per 1000 cohort members was the highest (10.2/1000) in 
the high-dose group in which thyroid doses were more than 1 Gy as compared with the 
low-dose group with thyroid doses less than 0.3 Gy (1.3/1000, p<0.0001). By contrast, after 
the 4th screening during 2006-08 (mean latency 20.9 years), such tendency was no longer 
observed (1.2/1000 and 1.5/1000 respectively, p<0.753). It therefore seems possible that 
the rapid progression of radiogenic PTCs in children at surgery might be associated with 
higher exposure doses as compared with radiogenic tumors in adolescents and adults 
which are characterized by the longer latency. 
To verify this supposition, we analyzed individual reconstructed 131I thyroid doses in all 
cases of radiogenic PTCs which have been calculated by a method described in a recent 
article [17] and in Chapter 2 of this monograph for thyroid tumors included in the Chernobyl 
Tissue Bank (CTB). Mean 131I thyroid dose in our cohort which included 239 children aged 0 
to 4 years at exposure was 1.016 Gy (95% CI 0.701-1.332; median 0.336 Gy; minimum 0.040 
Gy; maximum 24.110 Gy). 
In the comparison of three age groups with different latency by the Kruskal-Wallis 
nonparametric ANOVA, no significant differences between exposure doses were found. 
Although the median of doses was somewhat decreasing in the series children-adolescents-
adults, no significant linear trend was found (Table 5.10). A plausible explanation of the 
absence of significant differences between thyroid doses would be that all Ukrainian-
American cohort members had direct measurements of thyroid activity (see Chapter 2) 
unlike patients in the present study, who had direct measurements of thyroid activity only 
in 16.3% cases (39 out of 239). The accuracy of dose estimates in the Ukrainian-American 
cohort was obviously higher with narrower CI range. In addition, patients distributions by 
age at the time of Chernobyl (0 to 4 years) and at surgery (4 to 23 years) differed significantly 
from those included in the Ukrainian-American project [16,18,19] in which the age at 
exposure exceeded 4 years in most cases, there were practically no patients operated in 
childhood, and the age of operated adults reached 34 years. 
A more detailed analysis of mean thyroid doses for those pathological parameters that 
distinguished radiogenic PTCs from sporadic ones showed that doses were significantly 
higher in children/Females comparing with adults/Females. When comparing the doses of 
females and males, those were higher for males in all age groups, especially in adolescents 
and adults, but without significant difference (Table 5.11). 
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Analysis of dose relationship with РТС size (microcarcinoma vs other) demonstrated 
different trends in children, adolescents and adults. While in children the mean dose 
for microcarcinomas was insignificantly lower than in PTCs of larger size, in adolescents 
and adults microcarcinoma was associated with higher doses, and in adolescents such a 
difference was significant (Table 5.12). 
In patients of all age groups with non-encapsulated РТС mean doses were higher than 
in patients with fully encapsulated tumor (Table 5.13), but significant differences were not 
found either in children in whom this parameter was strongly associated with radiogenic 
cancer, or in older patients in whom  this association was absent. 
For the combined solid + solid-follicular subtypes of РТС, which were associated with 
radiogenic cancer in children, mean doses did not display statistically significant differences 
either in the series children-adolescents-adults or when the doses were compared to those 
for all other subtypes of РТС (Table 5.14). 
Morphological features of tumor agressiveness (intrathyroidal spread, extrathyroidal 
extension, nodal disease), were not associated with significant differences in mean doses 
in all age groups either. Also, no dose differences were found in patients with or without 
morphological manifestations of agressiveness (Tables 5.15-5.17). A significantly higher 
exposure dose was noted only in adolescents without intrathyroidal spread as compared 
to patients with such or with corresponding adults (Table 5.15). 
Tumor multifocality, which was marginally associated with sporadic PTC in adults, 
was associated in radiogenic carcinomas of this age group with a higher (compared 
with children and adolescents) exposure dose (Table 5.18) but no significance could be 
expected taking into account the range of dose estimates from 0.155 to 12.279 Gy in 5 
observations.
Table 5.10 
Latency and thyroid radiation doses in patients with radiogenic PTC 
(born before Chernobyl)













Mean 9.4 14.8 18.9 0.995 1.333 0.704
95 % CI 9.0-9.9 14.3-15.2 18.3-19.4 0.591-1.398 0.487-2.179 0.269-1.139
Minimum 3.8 11.7 14.8 0.048 0.040 0.044
Median 9.4 14.4 18.8 0.406 0.341 0.261
Maximum 13.8 17.9 22.6 16.584 24.110 12.280
p-value <0.0001 0.226
p-trend <0.0001 0.467
p-value <0.0001 a 0.801 a
p-value <0.0001 b <0.0001 c 0.098 b 0.182 c
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults
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Table 5.11 
Thyroid radiation doses in females and males with radiogenic PTC 
(born before Chernobyl)












Mean 1.023 0.962 0.459 0.953 2.075 1.317
95 % CI 0.970-1.476 0.320-1.607 0.275-0.714 0.187-1.721 0.208-4.359 0.379-3.014
Minimum 0.048 0.040 0.044 0.057 0.068 0.101
Median 0.459 0.327 0.240 0.329 0.366 0.434
Maximum 13.216 13.286 3.175 16.584 24.110 12.279
p-value 0.046 0.551
p-trend 0.113 0.472
p-value 0.235 a 0.234 d 0.295 e 0.139 f
p-value 0.015 b 0.217 c
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults; d  - children: female 
vs male;    e - adolescents: female vs male;   f - adults: female vs male; 
Table 5.12 
Thyroid radiation doses and tumor size in patients with radiogenic PTC 
(born before Chernobyl)












Mean 0.396 4.323 1.380 1.034 0.528 0.513
95 % CI 0.179-0.612 0.473-8.174 0.620-3.380 0.605-1.464 0.310-0.746 0.304-0.722
Minimum 0.152 0.203 0.087 0.048 0.070 0.044
Median 0.342 2.136 0.274 0.416 0.299 0.259
Maximum 0.715 24.110 12.279 16.584 4.508 3.175
p-value 0.022 0.115
p-trend 0.664 0.084
p-value 0.025 a 0.102 a
p-value 0.757 b 0.017 c 0.086 b 0.798 c
p-value 0.645 d 0.0006 e 0.905 f
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults; d  - children: ≤10 mm 




Thyroid radiation doses and full tumor encapsulation in patients with radiogenic PTC 
(born before Chernobyl)












Mean 0.327 0.612 0.362 1.032 1.462 0.866
95 % CI 0.126-0.527 0.092-1.315 0.161-0.563 0.607-1.457 0471-2.454 0.229-1.504
Minimum 0.083 0.087 0.044 0.048 0.040 0.087
Median 0.402 0.327 0.202 0.406 0.359 0.285
Maximum 0.540 3.400 1.626 16.584 24.110 12.279
p-value 0.424 0.732
p-trend 0.534 0.737
p-value 0.635 a 0.842 a
p-value 0.849 b 0.344 c 0.412 b 0.642 c
p-value 0.348 d 0.838 e 0.089 f
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults; d  - children: full 
encapsulation vs other;    e – adolescents: full encapsulation vs other;   f - adults: full encapsulation 
vs other
Table 5.14 
Thyroid radiation doses and combined Solid+Solid-Follicular subtype of PTC in patients 
born before Chernobyl










Mean 0.752 0.730 0.716 1.222 1.496 0.701
95 % CI 0.433-1.071 0.315-1.144 0.107-1.325 0.494-1.951 0.424-2.558 0.177-1.226
Minimum 0.056 0.089 0.045 0.048 0.040 0.044
Median 0.369 0.352 0.285 0.428 0.327 0.254
Maximum 6.880 2.160 3.015 16.584 24.110 12.279
p-value 0.855 0.134
p-trend 0.920 0.366
p-value 0.591 a 0.417 a
p-value 0.911b 0.966 c 0.052 b 0.212 c
p-value 0.387 d 0.814 e 0.654 f
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults; d  - children: SV+SFV vs 
other;    e – adolescents: SV+SFV vs other;   f - adults: SV+SFV vs other
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Table 5.15
Thyroid radiation doses and intrathyroidal spread in patients with radiogenic PTC 
(born before Chernobyl)












Mean 0.973 0.644 0.828 1.121 2.111 0.523
95 % CI 0.573-1.373 0.268-1.021 0.116-1.540 0.486-2.729 0.349-3.873 0.213-0.959
Minimum 0.048 0.040 0.045 0.096 0.072 0.044
Median 0.453 0.292 0.285 0.316 0.428 0.235
Maximum 16.584 4.595 12.279 13.216 24.110 3.175
p-value 0.238 0.067
p-trend 0.692
p-value 0.120a 0.196 a
p-value 0.289 b 0.725 c 0.308 b 0.028 c
p-value 0.436 d 0.039 e 0.436 f
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults; d  - children: intrathyroidal 
spread, yes vs no;    e – adolescents: intrathyroidal spread, yes vs no;   f - adults: intrathyroidal spread, 
yes vs no
Table 5.16 
Thyroid radiation doses and extrathyroidal extension in patients with radiogenic PTC 
(born before Chernobyl)












Mean 0.786 0.726 0.601 1.413 1.839 0.753
95 % CI 0.508-1.063 0.281-1.171 0.204-0.997 0.314-2.513 0.318-3.361 0.128-1.378
Minimum 0.048 0.046 0.045 0.065 0.040 0.044
Median 0.410 0.330 0.285 0.396 0.341 0.259




p-value 0.372 b 0.594 c 0.150 b 0.175 c
p-value 0.648 d 0.541 e 0.928 f
a  - children vs adolescents;    b - children vs adults;   c - adolescents vs adults; d  - children: extrathyroidal 
extension, yes vs no;   e – adolescents: extrathyroidal extension, yes vs no;  f - adults: extrathyroidal 




Thyroid radiation doses and lymph node metastases in patients with radiogenic PTC 
(born before Chernobyl)












Mean 0.983 0.692 0.642 1.020 2.057 0.727
95 % CI 0.560-1.407 0.294-1.090 0.149-1.135 0.106-1.934 0.296-3.819 0.148-1.306
Minimum 0.048 0.040 0.045 0.065 0.072 0.044
Median 0.416 0.251 0.247 0.397 0.390 0.261




p-value 0.186 b 0.855 c 0.463 b 0.028c
p-value 0.616 d 0.021 e 0.658 f
a  - children vs adolescents;   b - children vs adults;   c - adolescents vs adults; d  - children: lymph node 
metastases, yes vs no;  e – adolescents: lymph node metastases, yes vs no;  f - adults: lymph node 
metastases, yes vs no
Table 5.18 
Thyroid radiation doses and multifocality in patients with radiogenic PTC 
(born before Chernobyl)










Mean 0.496 0.888 2.736 1.027 1.386 0.515
95 % CI 0.172-0.821 -0.632-2.409 -3.889-9.361 0.598-1.459 0.448-2.324 0.324-0.703
Minimum 0.150 0.089 0.155 0.048 0.040 0/044
Median 0.457 0.251 0.403 0.397 0.350 0.254




p-value >0.999 b 0.432 c 0.070 b 0.093 c
p-value 0.944d 0.499e 0.289 f
a  - children vs adolescents;   b - children vs adults;   c - adolescents vs adults; d  - children: multifocality, 
yes vs no;  e – adolescents: multifocality, yes vs no;  f - adults: multifocality, yes vs no
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Given mean thyroid doses in patients of three age groups with radiogenic papillary 
carcinomas did not differ significantly for virtually all morphological characteristics under 
study, we performed an additional deepened analysis of the dose-response relationship. 
Those pathological parameters that appeared to be significant on the multivariate 
analysis of radiation-induced vs sporadic PTCs were examined for their association with 
thyroid dose using univariate and multivariate standard logistic regression modeling:
where a – a pathological parameter and z is: 
for the univariate analysis
z = Const + OR( D j )
where Const is a constant, OR(Di) is the Odds Ratio for the dose group Di (i=0, .. , 4), 
relative to the dose group D0 with the OR=1 (referent group). All exposed patients were 
subdivided in quartiles thereby determining the dose range for each quartile;
for the multivariate analysis:
z = Const + b P k+ OR( D j )
where Const is a constant, Pk – pathological parameters, OR(Dj) is the Odds Ratio for the 
dose group Dj relative to the dose group D0 with the OR=1 (referent group); 
Two types of logistic regression models were applied: 
 • patients were stratified by eight dose intervals (i=0, .. ,8);
 • a threshold dose model (two dose intervals) was used for which the reference dose
interval was determined by optimizing the model according to binomial maximum
likelihood.
The following pathological parameters (Pk) were tested for the multivariate analysis:
age at surgery (continuous; years); sex (categorical, M or F); tumor size ≤10 mm or  >10 
mm (categorical; yes or no); complete tumor capsule (categorical; no or yes); histological 
subtype (categorical; solid+solid follicular or other); lymph node metastases (categorical; 
yes or no); distant metastasis to the lung (categorical; yes or no); intrathyroidal spread 
(categorical; yes or no); extrathyroidal extension (categorical; yes or no); multifocality 
(categorical; yes or no). 
The linear or linear-quadratic terms for the dose were forcedly introduced as independent 
variable(s) in addition to the parameters used for the multivariate analysis of radiation-
induced vs. sporadic PTCs.
EPICURE software package was used for the analysis. Non-automatic backward 
elimination was applied to the full model that initially included all the variables listed 
above. The binomial maximum likelihood estimates and the likelihood-based 95% CI 
were calculated for parameters of all the above-introduced models. Likelihood ratio 
statistics were used to calculate p-values for the studied effects and to test the statistical 
significance of the respective parameters. The results of these analyses are presented 
in Tables 5.19-5.21. 
In children, the following pathological parameters were significantly different between 
radiation-induced and sporadic PTCs: absence of full tumor capsule, histological subtype 
(solid + solid-follicular vs other), intrathyroidal spread (yes vs no), and lymph node 
metastases (yes vs no), marginally (Table 5.19).
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Table 5.19  
Univariate and multivariate statistical analyses of association of different pathological 
parameters in exposed children
 Tumor capsule, children
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.1885   1.00 referent -
0.1885 - < 0.387 0.46 0.02-5.12 > 0.5
0. 387 - < 0.7923 1.50 0.23-12.1 > 0.5
0.7923 – 16.584 NA a NA NA
p-trend linear regression > 0.5 b
multivariate, stratified
Extrathyroidal extension 0.03 0.00-0.26 < 0.001 c
Thyroid dose (Gy)
< 0.110 1.00 referent -
0.110 - < 0.185 NA NA
0.185 - < 0.274 NA NA
0.274 - < 0.406 0.26 0.01-4.32 0.37
0.406 - < 0.547 1.48 0.12-20.9 > 0.5
0.547 - < 0.851 NA NA
0.851 - < 1.907 NA NA
1.907 – NA NA
linear dose model p-trend 0.1 b
multivariate, dose threshold
Extrathyroidal extension 0.06 0.00-0.43 0.004 c
Thyroid dose (Gy)
< 0.110 1.00 referent -
≥ 0.110 0.13 0.13-1.21 0.07 b
a there were no or too few cases in the given dose range to fit the model; b indicates non-significant 
association of full tumor encapsulation with thyroid dose; c indicates significantly decreased chance 
of fully encapsulated tumors among cases with extrathyroidal extension
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Continuation of Table 5.19
Histological subtype, children
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.1885   1.00 referent    -
0.1885 - < 0.387 1.64 0.58-4.76 0.35
0.387 - < 0.7923 1.24 0.44-3.58 > 0.5
0.7923 – 16.584 2.06 0.72-6.12 0.18
p-trend linear regression > 0.5 a
multivariate, stratified
Extrathyroidal extension 0.23 0.09-0.54 < 0.001 b
Thyroid dose (Gy)
< 0.110 1.00 referent    -
0.110 - < 0.185 1.22 0.26-5.94 > 0.5
0.185 - < 0.274 0.97 0.20-4.80 > 0.5
0.274 - < 0.406 1.88 0.40-9.22 0.42
0.406 - < 0.547 1.37 0.29-6.60 > 0.5
0.547 - < 0.851 0.80 0.16-3.81 > 0.5
0.851 - < 1.907 5.07 1.00-31.89 0.05
1.907 – 1.22 0.25-5.94 > 0.5
linear dose model p-trend 0.1 a
multivariate, dose threshold
Extrathyroidal extension 0.24 0.10-0.56 0.002 b
Thyroid dose (Gy)
< 0.851 1.00 referent    -
≥ 0.851 2.03 0.81-5.23 0.31 a
a indicates non-significant association of histological subtype (solid+solid-follicular) with thyroid 
dose; b indicates significantly decreased chance of tumors with growth pattern other than solid or 
solid-follicular among cases with extrathyroidal extension
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Continuation of Table 5.19
Intrathyroidal spread, children
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.1885   1.00 referent -
0.1885 - < 0.387 0.38 0.07-1.54 0.18
0.387 - < 0.7923 0.58 0.11-2.61 0.48
0.7923 – 16.584 1.56 0.24-12.61 > 0.5
p-trend linear regression 0.43 a
multivariate, stratified
pT  8.48 2.05-43.28 0.003 b
pN  7.96 1.90-41.07 0.004 c
Thyroid dose (Gy)
< 0.110 1.00 referent -
0.110 - < 0.185 0.96 0.03-20.62
0.185 - < 0.274 0.78 0.03-13.42
0.274 - < 0.406 0.21 0.01-3.97 0.37
0.406 - < 0.547 0.68 0.02-11.27 > 0.5
0.547 - < 0.851 1.56 0.05-31.79
0.851 - < 1.907 3.33 0.08-160.1
1.907 – 1.52 0.04-54.32
linear dose model p-trend 0.1 a
multivariate, dose threshold
pT  8.21 2.27-34.17 0.001 b
pN  6.54 1.73-28.86 0.001 c
Thyroid dose (Gy)
< 0.547 1.00 referent -
≥ 0.547 2.80 0.71-13.57 0.147 a
a indicates non-significant association of intrathyroidal spread with thyroid dose; b indicates 
significantly increased chance of intrathyroidal spread among tumors with advanced pT category; 
c indicates significantly increased chance of intrathyroidal spread among cases featuring lymph 
node metastases 
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Continuation of Table 5.19
Lymph node metastases, children
Parameters OR 95% CI     p-value
univariate
Thyroid dose (Gy)
< 0.1885   1.00 referent     -
0.1885 - < 0.387 0.76 0.24-2.33 > 0.5
0.387 - < 0.7923 0.76 0.24-2.33 > 0.5
0.7923 – 16.584 0.84 0.27-2.65 > 0.5
p-trend linear regression > 0.5 a
multivariate, stratified
Sex 2.95 1.03-9.55 0.042 b
Tumor capsule  0.11 0.01-0.84 0.034 c
M 4.36 1.00-31.23 0.049 d
Vascular invasion  0.05 0.01-0.21 0.004 e
Thyroid dose (Gy)
< 0.110 1.00 referent      -
0.110 - < 0.185 1.48 0.20-10.8 > 0.5
0.185 - < 0.274 0.89 0.15-5.42 > 0.5
0.274 - < 0.406 2.21 0.26-18.37 0.45
0.406 - < 0.547 2.15 0.29-16.09 0.46
0.547 - < 0.851 0.81 0.15-4.44 > 0.5
0.851 - < 1.907 0.58 0.10-3.49 > 0.5
1.907 – 2.26 0.31-16.42 0.42
linear dose model p-trend > 0.5 a
multivariate, dose threshold
Sex  2.89 1.05-9.33 0.041 b
Tumor capsule  0.15 0.01-0.93 0.036 c
M 4.41 1.00-28.41 0.048 d
Vascular invasion  0.05 0.01-0.20 < 0.001 e
Thyroid dose (Gy)
< 0.110 1.00 referent     -
≥ 0.110 1.56  0.44-4.27 0.72 a
a indicates non-significant association of lymph node metastases with thyroid dose; b indicates 
significantly higher chance of lymph node metastasis in males; c indicates significantly decreased 
chance of lymph node metastases among cases with fully encapsulated tumor; d indicates significantly 
increased chance of lymph node metastases among cases with distant metastases; e indicates 
significantly decreased chance of lymph node metastases among cases without vascular invasion
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In adolescents, only one pathological parameter was significantly different between 
radiation-induced and sporadic PTCs: extrathyroidal extension (yes vs no) (Table 5.20).
Table 5.20  
Univariate and multivariate statistical analyses of association of extrathyroidal extension 
in exposed adolescents
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.1938 1.00 referent -
0. 1938 - < 0.341 0.70 0.17-2.77 > 0.5
0.341 - < 0.802 1.43 0.36-5.81 > 0.5
0.802 – 24.11 0.45 0.10-1.88 0.28
p-trend linear regression 0.19 a
multivariate, stratified
pN 7.18 1.76-39.45 0.005 b
Vascular invasion   0.11   0.02-0.47 0.002 c
Thyroid dose (Gy)
< 0.095 1.00 referent -
0.095 - < 0.194 0.61 0.05-6.20 > 0.5
0.194 - < 0.264 1.54 0.13-20.72 > 0.5
0.264 - < 0.341 0.74 0.05-8.96 0.49
0.341 - < 0.425 2.19 0.17-32.21 > 0.5
0.425 - < 0.802 3.42 0.28-49.84 > 0.5
0.802 - < 2.449 0.47 0.04-5.06 0.42
2.449 – 0.67 0.04-10.43 0.37
linear dose model p-trend > 0.5 a
multivariate, dose threshold
pN 7.18 b 1.76-39.45 0.005 b
Vascular invasion  0.11 c  0.02-0.47 0.002 c
Thyroid dose (Gy)
< 0.194 1.00 referent -
≥ 0.194 1.88 0.08-23.17 0.52 a
a indicates non-significant association of extrathyroidal extension with thyroid dose; b indicates 
significantly increased chance of extrathyroidal extension among cases with lymph node metastases; 
c indicates significantly decreased chance of extrathyroidal extension among cases without vascular 
invasion
In adults, the following pathological parameters were significantly different between 
radiation-induced and sporadic PTCs: extrathyroidal extension (yes vs no), lymph node 
metastases (yes vs no), and  multifocality (yes vs no, marginally) (Table 5.21).
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Table 5.21 
Univariate and multivariate statistical analyses of association of different pathological 
parameters in exposed adults
Lymph node metastases, adults
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.160 1.00 referent -
0. 160 - < 0.261 0.55 0.09-2.82 0.47
0.261 - < 0.560 0.73 0.14-3.51 > 0.5
0.560 - 12.28 0.74 0.15-3.52 > 0.5
p-trend linear regression > 0.5 a
multivariate, stratified
Sex 0.05 0.02-0.53 0.044 b
Tumor capsule 0.01 0.00-0.22 0.034 c
Vascular invasion  0.02 0.00-0.17 < 0.001 d
Thyroid dose (Gy)
< 0.102 1.00 referent -
0.102 - < 0.155 0.03 0.00-1.79 0.13
0.155 - < 0.202 0.20 0.00-5.35 0.35
0.202 - < 0.261 0.01 0.00-0.20 0.012
0.261 - < 0.396 0.13 0.00-2.44 0.19
0.396 - < 0.562 0.04 0.00-1.54 0.13
0.562 - < 1.260 0.01 0.00-0.21 0.013
1.260 – 0.12 0.00-3.04 0.23
linear dose model p-trend > 0.5 a
multivariate, dose threshold
Sex 0.06 0.03-0.51 0.042 b
Tumor capsule 0.01 0.00-0.21 0.036 c
Vascular invasion  0.02 0.00-0.18 < 0.001 d
Thyroid dose (Gy)
< 0.102 1.00 referent -
≥ 0.102 0.08 0.00-1.88 0.14 a
a indicates non-significant association of lymph node metastases with thyroid dose; b indicates 
significantly decreased chance of lymph node metastasis in males; c indicates significantly decreased 
chance of lymph node metastases in cases of fully encapsulated tumors; d indicates significantly 
decreased chance of lymph node metastases among cases without vascular invasion
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Continuation of Table 5.21
Multifocality, adults
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.160 1.00 referent -
0. 160 - < 0.261 NA a NA NA
0.261 - < 0.560 3.50 0.34-75.98 0.27
0.560 – 12.28 1.00 0.04-26.97 > 0.5
p-trend linear regression 0.12 b
multivariate, stratified
Tumor size 0.10 0.01-0.69 0.021 c
Thyroid dose (Gy)
< 0.110 1.00 referent -
0.110 - < 0.185 NA NA > 0.5
0.185 - < 0.274 NA NA > 0.5
0.274 - < 0.406 NA NA > 0.5
0.406 - < 0.547 NA NA > 0.5
0.547 - < 0.851 NA NA > 0.5
0.851 - < 1.907 NA NA > 0.5
1.907 – NA NA > 0.5
Linear/quadratic dose model p-trend 0.11 b
multivariate, dose threshold
Tumor size 0.10   0.01-0.69 0.026 c
Thyroid dose (Gy)
< 0.406 1.00 referent -
≥ 0.406 4.05 0.49-87.00 0.20 b
a there were no or too few cases in the given dose range to fit the model; b indicates non-significant 
association of multifocality with thyroid dose; c indicates significantly decreased chance of 
multifocality among small tumors
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Continuation of Table 5.21
Extrathyroidal extension, adults
Parameters OR 95% CI p-value
univariate
Thyroid dose (Gy)
< 0.160 1.00 referent -
0. 160 - < 0.261 0.80 0.16-3.91  > 0.5
0.261 - < 0.560 1.00 0.21-4.68 > 0.5
0.560 – 12.28 1.00 0.20-4.66 > 0.5
p-trend linear regression > 0.5 a
multivariate, stratified
Tumor capsule 0.05     0.00-0.37   0.002 b
Vascular invasion   0.08   0.01-0.36 < 0.001 c
Thyroid dose (Gy)
< 0.102 1.00 referent -
0.102 - < 0.155 0.78 0.02-24.50 > 0.5
0.155 - < 0.202 0.57 0.03-11.74 > 0.5
0.202 - < 0.261 0.23 0.01-4.56 0.32
0.261 - < 0.396 0.51 0.02-9.09 > 0.5
0.396 - < 0.562 0.56 0.03-10.18 > 0.5
0.562 - < 1.260 0.15 0.00-3.24 0.23
1.260 – 0.32 0.02-6.00 0.44
linear dose model p-trend > 0.5 a
multivariate, dose threshold
Tumor capsule 0.03 b 0.00-0.36  0.002 b
Vascular invasion   0.07  0.00-0.32 < 0.001 c
Thyroid dose (Gy)
< 0.102 1.00 referent -
≥ 0.102 0.42 0.04-4.45 0.45 a
a indicates non-significant association of extrathyroid extension with thyroid dose; b indicates 
significantly decreased chance of extrathyroid extension in encapsulated tumors; c indicates 
significantly decreased chance of extrathyroid extension among cases without vascular invasion.
Thus, as shown by the results of either univariate or any type of multivariate analysis 
(Tables 5.19-5.21), no evidence of significant association with thyroid dose was found for 
any pathological parameter tested in all age groups. 
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The only exception was a marginally significant association of the combined solid + 
solid-follicular subtype of РТС in children with the dose range from 0.851 to 1.907 Gy (Table 
5.19), whose lower limit almost coincides with mean thyroid exposure dose (0.752 Gy) in 
children with these growth patterns (Table 5.14). In view of recently published results of 
molecular genetic study of PTCs identified in the Ukrainian-American cohort, which has 
established a positive association between RET/PTC rearrangements and 131I thyroid dose 
with an inflection point at 1.6 Gy [20], this fact draws attention. Notably, namely RET/
PTC rearrangements, RET/PTC3 in particular, are most common among children and are 
associated with the solid and solid-follicular tumor structure [21, 22]. 
As a whole, radiogenic papillary carcinomas in children exposed after the Chernobyl 
accident at the age under 4 years (mean 131I thyroid dose 1.016 Gy) and subdivided by their 
age at surgery into three groups (children, adolescents and adults) significantly differed from 
sporadic carcinomas in age-matched groups for a number of morphological parameters. 
Univariate and multivariate statistical analyses revealed the most substantial differences 
in both histoarchitectonics and invasive features of radiogenic PTCs, demonstrating their 
more aggressive behaviour especially well seen in age-matched groups of children. In 
adolescents and adults, morphological differences between radiogenic and sporadic 
tumors were found only for isolated parameters and those were revealed only by 
multivariate analysis. 
Such a “convergence” of morphological differences between radiogenic and sporadic 
PTCs with increasing patients’ age (hence the latency of radiogenic tumors), was not 
associated with the lower thyroid exposure dose or a certain dose range for most 
morphological manifestations of tumor agressiveness. A significant association was noted 
only between solid + solid-follicular subtype and a dose range from 0.851 to 1.907 Gy in 
children, for which an association with RET/PTC rearrangements was recently reported [20]. 
It is quite possible that future molecular genetic investigations employing advanced 
technologies, e.g next generation sequencing, will discover new genetic/epigenetic 
alterations unknown at present that are associated with radiation thyroid carcinogenesis, 
which, in turn, will allow better understanding of the mechanisms underlying more 
pronounced morphological signs of aggressiveness of radiogenic PTCs with short latency. 
Continuous ongoing verifications of thyroid doses in children and adolescents of 
Ukraine after Chernobyl aimed at the reduction of uncertainties in dose estimates [23, 24] 
are highly important for the subsequent analyses of dose-response relationship. These 
would possibly allow establishing more confident associations between morphological 
parameters and exposure doses. 
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